Two patients with antiphospholipid antibody developed disseminated intravascular coagulation.
暂无分享,去创建一个
T. Nobori | H. Wada | H. Mizutani | K. Habe | H. Suzuki | Naomi Ito-Habe
[1] S. Pierangeli,et al. Pathogenesis of the Antiphospholipid Syndrome , 2012, Seminars in Thrombosis & Hemostasis.
[2] T. Koike,et al. Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndrome. , 2011, Current vascular pharmacology.
[3] V. Pengo. APS--controversies in diagnosis and management, critical overview of current guidelines. , 2011, Thrombosis research.
[4] T. Takano,et al. Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. , 2008, Biochemical and biophysical research communications.
[5] A. Davis,et al. A review of the sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised sapporo criteria add value? , 2007, The Journal of rheumatology.
[6] G. Espinosa,et al. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients , 2005, Annals of the rheumatic diseases.
[7] H. Wada. [Disseminated intravascular coagulation]. , 2004, [Rinsho ketsueki] The Japanese journal of clinical hematology.
[8] F B Taylor,et al. Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.
[9] Chan Jun-mi,et al. International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS) , 2008 .
[10] R. Cervera,et al. 41 – THE CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME , 2004 .